If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFeedback Regulatory News (FDBK)

Share Price Information for Feedback (FDBK)

Share Price is delayed by 15 minutes
Get Live Data
7.10    0.00 (0.00%)
Bid:
7.00
Ask:
7.20
Spread: 0.20 (2.857%)
Market Cap: £3.11m
FDBK Live PriceLast checked at - London Stock Exchange

Intraday Feedback Share Chart

Issue of Equity

2 Mar 2007 14:31

Feedback PLC02 March 2007 Feedback plc ("the Company") Issue of Equity and Compulsory Conversion of Preference Shares Feedback PLC announces that yesterday it received conversion notices fromcertain holders of the Company's 10 per cent. (net) convertible redeemablecumulative preference shares of £1 ("Preference Shares") to convert, inaggregate 405,719 Preference Shares having a nominal paid up value of £543,405into 2,717,025 ordinary shares of 10p each in the Company ("Ordinary Shares").Further details regarding the Preference Share holders who have converted theirPreference Shares are set out below. Pursuant to a block listing, granted on 28 November 2006, 2,468,329 OrdinaryShares have been admitted to AIM. An application has been made for a further248,696 Ordinary Shares to be admitted to AIM and it is anticipated that theshares will be admitted to trading on AIM with effect from Thursday 8 March2007. Following this conversion of Preference Shares, there will be 15,099,196Ordinary Shares in issue and 365,095 Preference Shares. Furthermore, as aconsequence of these conversions, 75 per cent. of the holders of PreferenceShares have now exercised their right to convert their Preference Shares intoOrdinary Shares. Pursuant to the Articles of Association of the Company, theCompany has given four weeks notice to require all holders of Preference Shareswhich have not converted to compulsorily convert, from the expiry of suchnotice, the whole of their holding of Preference Shares into new OrdinaryShares. The basis of conversion is 5 ordinary shares for every £1 in nominal amount ofpreference shares. Arrears of dividend due to holders of Preference Shares isconverted on the same basis so that 5 ordinary shares will be issued for every£1 of arrears of dividend. The notice will expire on 30 March 2007 at whichtime the remaining Preference Shares will be converted into Ordinary Shares. Although the Ordinary Shares to be issued on conversion will not rank for anydividend in respect of the year ended 31 March 2007, they will rank pari passuin all other respects with the existing Ordinary Shares. Preference Sharesconverted in 2007 will not rank for Preference Share dividends after conversion. Assuming no further conversions during the notice period, the remaining 365,095Preference Shares having a nominal paid up value of £502,529 will convert into2,512,645 new Ordinary Shares and there will then be 17,611,841 Ordinary Sharesin issue. Application has been made to AIM and it is anticipated that admission of the2,512,645 new Ordinary Shares, arising upon compulsory conversion, to trading onAIM will become effective and that dealings will commence on Monday 2 April. Changes in interests As referred to above, the Company yesterday received conversion notice fromcertain Preference Share holders, as detailed below: 1. In their capacity as trustees of the Blackman Will Settlement, DavidHarding, Chairman, and John Westcott, a non-executive director, converted235,405 Preference Shares with a nominal paid up value of £315,645 into1,577,325 Ordinary Shares; 2. John Westcott and Mrs HF Westcott converted 51,000 Preference Shareswith a nominal paid up value of £68,048 into 340,240 Ordinary Shares; and 3. the trustees of the Westcott Family Trust converted 119,314 PreferenceShares with a nominal value of £159,892 into 799,460 Ordinary Shares. Accordingly, David Harding is now non-beneficially interested in 4,067,461Ordinary Shares representing 26.94per cent. of the Company's current issuedOrdinary Share capital (prior to the compulsory conversion process). In addition, John Westcott is now beneficially interested in 287,088 OrdinaryShares representing 1.90 per cent. of the Company's current issued OrdinaryShare capital (prior to the compulsory conversion process) and non-beneficiallyinterested in 4,067,461Ordinary Shares representing 26.94 per cent. of theCompany's current issued Ordinary Share capital (prior to the compulsoryconversion process). Finally, the Westcott Family Trust now holds 2,991,369 Ordinary Sharesrepresenting 19.81per cent. of the Company's current issued Ordinary Sharecapital (prior to the compulsory conversion process). 2 March 2007 Enquiries: Charles Stanley Securities 020 7149 6457 Philip Davies This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
21st Mar 20247:00 amRNSFurther CDC Pilot Programme Secured
23rd Feb 202411:03 amRNSHolding(s) in Company
21st Feb 20247:00 amRNSHalf-year Report
21st Feb 20247:00 amRNSMedical Imaging Partnership Pilot Agreement
6th Feb 20247:00 amRNSNotice of Results & Investor Presentation
19th Dec 20237:01 amRNSHalf Year Trading Update
19th Dec 20237:00 amRNSAward of Pilot Funding
26th Oct 20232:24 pmRNSResult of AGM
25th Oct 20235:53 pmRNSDirector Dealing
27th Sep 202312:15 pmRNSNotice of AGM
12th Sep 20237:00 amRNSFinal Results
5th Sep 20237:00 amRNSNotice of Results & Investor Presentation
19th Jun 20237:00 amRNSYear End Trading Update
4th Apr 20237:00 amRNSBleepa-CareLocker contract extension with QVH
7th Feb 20237:00 amRNSHalf-year Report
3rd Feb 20233:56 pmRNSHolding(s) in Company
11th Jan 20237:00 amRNSNotice of Results, Analyst & Investor Presentation
22nd Dec 202212:08 pmRNSDirector/PDMR Shareholding: Correction
22nd Dec 20227:00 amRNSDirector/PDMR Shareholding
19th Dec 20227:00 amRNSHalf Year Trading Update
1st Nov 20223:36 pmRNSTotal Voting Rights
13th Oct 20222:55 pmRNSResult of AGM & Proposed Share Consolidation
29th Sep 20223:46 pmRNSHolding(s) in Company
20th Sep 20223:26 pmRNSNotice of AGM & Proposed Share Consolidation
20th Sep 20227:00 amRNSFinal Results
13th Sep 20227:00 amRNSNotice of Results & Investor Presentation
6th Sep 20227:00 amRNS12 month contract for Sussex CDC pilot extension
19th Jul 20227:00 amRNSContract Update
16th Jun 20227:00 amRNSYear End Trading Update
1st Jun 20227:00 amRNSTrading Update & Director Appointment
12th May 202212:44 pmRNSChange of Registered Office
12th Apr 20227:00 amRNSBleepa wins two NHS Contract Awards
31st Mar 20227:00 amRNSBleepa TB Screening Pilot Now Live in Odisha
23rd Feb 20227:00 amRNSGrant of Options and PDMR dealing
10th Feb 20227:00 amRNSInterim Results
31st Jan 20227:00 amRNSNotice of Results
13th Dec 20217:00 amRNSPartnership with Amazon Web Services
6th Dec 20213:06 pmRNSHolding(s) in Company
2nd Dec 202110:20 amRNSDirector/PDMR Shareholding
2nd Dec 20219:54 amRNSHolding(s) in Company
1st Dec 20214:27 pmRNSHolding(s) in Company
1st Dec 20213:09 pmRNSHolding(s) in Company
30th Nov 20214:05 pmRNSHolding(s) in Company
29th Nov 20211:36 pmRNSDirector Appointment
29th Nov 20211:35 pmRNSResults of AGM, Open Offer, Issue of Equity & TVR
18th Nov 202112:15 pmRNSHolding(s) in Company
16th Nov 20214:35 pmRNSPrice Monitoring Extension
2nd Nov 20211:52 pmRNSResult of Placing
2nd Nov 20217:01 amRNSProposed Placing and Open Offer
2nd Nov 20217:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.